Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
  
1
2345
6
7
8
9
10
1112
13141516171819
20212223242526
2728293031  
 
  Archive  
 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More



Comments (0) | Trackbacks (0) | Permalink


| 1 |

 
 
  Tags
 
health plan nicotine addiction behavioral health care services pain killers ER vicodin behavioral healthcare services prometa Opioid Medications flumazenil reducing craving over-the-counter substances data mining identification hydrocodone drinking alcohol drinking fentanyl communication mental health methamphetamine dependence opioid abuse relapse naloxone stress SD members recovery network behavioral health care OnTrak codeine opiod-based relapse prevention anxiety Opioid Treatment reduction in use recovery health reform post-traumatic stress disorder vivitrol physician- patient relations opioid-drug interactions substance dependence health insurance sugar high-utilizing UnitedHealthcare buprenorphine ADHD methadone emergency room opioid substance dependence costs trauma methamphetamine drug addiction muscle relaxant contract suboxone painkillers craving score behavioral health percocet gabapentin opiod abuse health insurance predictive modeling opiates sober Health Care Utilization psychosocial narcotic OxyContin alcoholism pain medication oxycodone social network cocaine PTSD cocaine treatment care coaching behavioral healthcare Journal of Psychopharmacology mental illness randomized urine drug screen Catasys craving morphine CIWA chronic pain hospitalizations prescriptions drug treatment medical costs drug abuse alcohol drug addicts Research Across America dependence issues cigarettes pain pills Raymond Anton overdose SD health insurance placebo-controlled depression medical facebook alcohol treatment primary care Harold Urschel placebo hospital medical and behavioral costs ADD alcohol dependence addict Co Occurring Disorders heroin opioid antagonist depression screening smoking binge drinking marijuana double-blind bipolar disorder diabetes substance dependence addiction treatment withdrawal stratified drug use meth treatment sobriety stimulants substance use disorder opioid overdose reduction in craving
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy
 
  Copyright © 2011 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025